Full-Time
Distribution Clerk 1
Streck
201-500 employees
Clinical laboratory products for accurate diagnostics
No salary listed
La Vista, NE, USA
In Person
Occasional short trips into cold walk-in coolers; domestic or international travel is rarely required.
 Clerical & Data Entry (1) |
|---|
Get referred to Streck
See people who can refer or advise you
- A high school diploma, GED, or demonstrated success in a related role is required.
- Strong attention to detail and solid general math skills are required.
- A dependable, organized approach and clear verbal and written communication are required.
- The ability to work cooperatively with others in a fast-paced environment is required.
- The ability to learn new systems and equipment, including warehouse management system software and scanning devices, is required.
- The role requires standing and walking, lifting up to 50 pounds occasionally, and wearing required protective equipment for stretches of up to two and a half hours.
- Pack and ship standing orders, daily orders, international shipments, private-label orders, promotional samples, and referee samples according to established work instructions.
- Pull and verify orders using the warehouse management system and barcode scanners.
- Prepare international and hazardous-material shipments and complete all required documentation.
- Package temperature-sensitive products with the correct amount of ice to protect product integrity during transit.
- Set up and operate packaging-line equipment, including shrink-wrap machines and pallet jacks.
- Count and verify products released from Quality Control before shipment.
- Follow safety, Food and Drug Administration, and International Organization for Standardization regulatory requirements and maintain accurate documentation.
- Keep the workspace clean, organized, and ready for the next order.
Streck makes products and solutions for clinical and research laboratories to help them deliver accurate test results. Their offerings include reagents, controls, and other lab materials used in diagnostics, helping labs advance diagnostic workflows and support better patient outcomes. The products are manufactured in La Vista, Nebraska and shipped to thousands of labs worldwide, enabling broad accessibility and consistent performance across sites. Streck differentiates itself through its long history (founded in 1971), established manufacturing base, and global reach, which together emphasize reliability, quality control, and support for diverse lab needs. The company’s goal is to enable laboratories to provide reliable results that improve diagnoses and patient health.
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
La Vista, Nebraska
Founded
1971
Get referred to Streck
See people who can refer or advise you
Simplify's Take
What believers are saying
- FDA clearance on May 19, 2026 expands Streck into sepsis verification workflows.
- CD-Chex Daily's 51-marker coverage targets high-volume spectral cytometers and modern QC demand.
- Nucleic Acid Plus BCT extends stabilization to cfDNA, cfRNA, EVs, and proteins.
What critics are saying
- Most 2026 launches remain research-use-only, limiting revenue capture and regulatory defensibility.
- Nebraska Supreme Court's January 2026 appraisal ruling highlights lingering shareholder-value litigation risk.
- DiaSorin, flow-cytometry incumbents, and transport-media rivals can compress Streck's pricing by 2027.
What makes Streck unique
- Since 1971, Streck built patient-like QC controls for hematology, flow cytometry, and molecular labs.
- Streck's 2026 portfolio spans FDA-cleared blood-culture controls and room-temperature, ready-to-use workflows.
- Madison Industries owns Streck, giving it capital and distribution leverage across diagnostics.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Company News
Streck gets IVD clearance for MDx-Chex controls, launches blood culture tube. May 19, 2026 - Streck has received in vitro diagnostic clearance for three MDx-Chex controls for sepsis testing. MDx-Chex for BCY, MDx-Chex for BCP, and MDx-Chex for BCN are patient-like, ready-to-use, full-process molecular quality controls designed for verification of the Diasorin Liaison Plex yeast, Gram-positive, and Gram-negative blood culture assays, respectively. The controls are supplied in 10 single-use vial kits and feature room temperature storage. In a separate release, Streck announced the launch of its Nucleic Acid Plus BCT blood collection tube. Formerly known as Protein Plus BCT, this product has expanded its intended use claims to include cell-free DNA, cell-free RNA, extracellular vesicles, and select plasma proteins in an aim to better suit downstream multianalyte applications. Nucleic Acid Plus BCT provides stabilization of whole blood samples at ambient temperature (18°-25°C), with cfDNA and cfRNA remaining stable in stored samples for up to seven days and EVs and select plasma proteins remaining stable for up to five days. This allows for multianalyte analysis from a single draw. The tube's proprietary preservative reagent stabilizes nucleated blood cells, red blood cells, and platelets while minimizing ex vivo hemolysis and platelet activation. Nucleic Acid Plus BCT is for research use only and available as a 5-mL configuration in packs of six, boxes of 100, or cases of 1,000. A 10-mL configuration is expected to launch later this year.
Streck's CD-Chex(TM) Daily delivers 51-marker coverage in a single, assayed vial for standardized flow cytometry QC. May 4, 2026 La Vista, Nebraska - Streck is pleased to announce the launch of CD-Chex(TM) Daily, the newest addition to the CD-Chex line of flow cytometry quality controls. CD-Chex Daily is a ready-to-use, assayed quality control designed to simplify and modernize daily QC workflows for flow cytometry laboratories. CD-Chex Daily provides comprehensive coverage across 51 markers in a single vial, with markers spanning surface, intracellular and leukocyte scatter populations, including CD200, TRBC1, cMPO, CD27, CD81, CD79b CD36, cCD79a, CD79b, cKappa, cLambda and more, for broad panel support. CD-Chex Daily supports modern high-volume spectral cytometers and integrates seamlessly with Streck's STATS(R) interlaboratory QC Program. The control's standardized assayed ranges meet CAP, CLIA, CLSI, and ISO 15189 requirements, limiting reliance on fragmented QC methods and supporting consistent comparability across instruments and overtime. ""Labs have been asking for a single control that keeps pace with complex panels and modern instrumentation," said Mirta Gamez, MT(ASCP), CLS, Associate Director of Hematology. "CD-Chex Daily delivers that - reducing costs, minimizing variability, and supporting compliance from day one." Supplied in a 3.0 mL pierceable plastic vial, available in single (Cat. No. 230695), two-pack (Cat. No. 230696), and five-pack (Cat. No. 230697) configurations, CD-Chex Daily provides 90-day closed-vial and 30-day open-vial stability to support labs of all testing volumes. CD-Chex Daily is for Research Use Only. Not for use in diagnostic procedures. About Streck, Inc. Established in 1971, Streck provides solutions that ensure every result counts by empowering clinical and research laboratories to reliably deliver accurate results, advance diagnostics and enable healthier, happier lives for patients everywhere. Streck products are manufactured in La Vista, Nebraska, and delivered to thousands of labs worldwide.
Streck launches new MDx-Chex controls for molecular diagnostic assays.
LA VISTA, Neb., June 3, 2025 /PRNewswire/ -- Streck is excited to announce the release of an updated version of the Streck ARM-D® Kit, OXA that detects an additional 36 allelic variants in 3 new antimicrobial resistance (AR) gene families. This expanded coverage is in response to customer feedback, particularly the member laboratories of the Antimicrobial Resistance Laboratory Network (ARLN) and the Centers for Disease Control and Prevention (CDC), who have identified gene families and allelic variants of increasing diversity and relevance and require a surveillance method that can effectively detect them. Of particular interest to these labs is effective detection of the variants of OXA-235, OXA-236 and OXA-237 in the OXA-134 family, as well as OXA-327-like and OXA-198-like beta-lactamase enzymes."The expansion of the Streck ARM-D Kit, OXA demonstrates our dedication to ensuring our products meet the needs of our customers in public health laboratories and emphasizes our commitment to make a global impact through solutions that improve infectious disease testing strategies," said Chris Connelly, director of Business Segment – Molecular. "We're proud to be a trusted resource for laboratories working hard in the fight against antimicrobial resistance."Streck's ARM-D kits allow for the cost-effective and comprehensive detection of more than 2,000 allelic variants across 25 AR gene families. Results from the kits demonstrate 100% concordance with whole genome sequencing (WGS) data from the same samples, for the targeted AR variants. The ARM-D kits are often used as a pre-WGS screening method to reduce the cost of AR surveillance in public health laboratories in the United States and other parts of the world.Streck ARM-D Kit, OXA is For Research Use Only
Streck is partnering with Longhorn Vaccines and Diagnostics to distribute its flagship product, PrimeStore(R) Molecular Transport Media (MTM), worldwide.